Asia-Pacific anticoagulants market size is anticipated to reach $15.7 billion by 2035 and is projected to grow at a CAGR of 5.7% from 2025 to 2035, according to a new report by Orion Market Research. The Asia-Pacific anticoagulant market is characterized by expanding pharmaceutical production capacity, improving healthcare infrastructure, and the growing presence of both regional drug manufacturers and multinational pharmaceutical corporations. The region continues to strengthen its position within the global cardiovascular therapeutics landscape, driven by rising prevalence of atrial fibrillation, deep vein thrombosis, and other thromboembolic disorders.

US flexible electronics market was valued at $5,722.1 million in 2025 and is projected to reach $9,705.7 million by 2035, growing at a CAGR of 5.5% during the forecast period (2026-2035).  Expansion of government-supported digital health initiatives and policy direction encouraging wearable device adoption is emerging as a major structural growth driver for the US flexible electronics market. According to US Department of Health and Human Services plans to promote large-scale adoption of wearable health devices, with leadership emphasizing a long-term vision where wearable monitoring becomes widely integrated into everyday healthcare management. 

US prostate cancer diagnostic and therapeutic market was valued at $8,250.5 million in 2025 and is projected to reach $20,091.0 million by 2035, growing at a CAGR of 9.4% during the forecast period (2026-2035). Rising prostate cancer incidence in the US is reinforcing long-term demand for advanced diagnostics and therapeutics. According to the American Cancer Society’s Cancer Statistics 2025, prostate cancer incidence increased at the steepest rate among common cancers, rising by approximately 3% annually between 2014 and 2021. In 2025 alone, the US is expected to record about 2.04 million new cancer cases, indicating a sustained and expanding oncology patient pool. This upward trend in prostate cancer diagnoses is directly expanding the addressable market for PSA testing, genomic profiling, PSMA-PET imaging, targeted therapies, radioligand treatments, and next-generation hormonal agents.

Global fiber patch panel & tray market size is anticipated to reach $9.5 billion by 2035 and is projected to grow at a CAGR of 8.1% from 2025 to 2035, according to a new report by Orion Market Research. The global fiber patch panel and tray market is witnessing steady growth as organizations increasingly depend on advanced communication infrastructures to accommodate the rising demand for high-speed data transmission. Enterprises, telecommunications providers, and service operators are managing escalating volumes of data traffic driven by cloud computing platforms, enterprise applications, and interconnected digital services. Fiber patch panels and trays serve a critical function in ensuring reliable, high-performance communication across modern network environments. These solutions are extensively deployed in telecommunications networks, enterprise communication systems, and large-scale data centers to facilitate efficient and uninterrupted data transfer.

UK prostate cancer diagnostic and therapeutic market was valued at $845.5 million in 2025 and is projected to reach $1,971.3 million by 2035, growing at a CAGR of 8.9% during the forecast period (2026-2035). The emergence of next-generation immunotherapies such as VIR-5500 is creating a strong growth catalyst for the global prostate cancer therapeutics market. Prostate cancer remains the most commonly diagnosed cancer among men in several countries, including the UK, with approximately 1.5 million new cases diagnosed each year globally. According to Cancer Research UK, more than 12,000 men die annually in the UK from the disease, indicating the urgent need for more effective and durable treatment options. Historically, prostate cancer has been considered an immune-cold tumor, meaning it has shown limited responsiveness to conventional immunotherapy approaches.

Prostate cancer diagnosis & treatment market was valued at $21,428.0 million in 2025 and is projected to reach $51,381.4 million by 2035, growing at a CAGR of 9.2% during the forecast period (2026-2035). The increasing incidence of prostate cancer is a key driver underpinning demand for diagnosis and treatment services in the market. According to the American Cancer Society, in the US alone, indicate that over 313,780 new prostate cancer cases were expected in 2025, accounting for about 30% of all male cancer diagnoses, and approximately 35,770 deaths from the disease were projected in the same year.

Global fiber optic connectivity market size is anticipated to reach $79.0 billion by 2035 and is projected to grow at a CAGR of 9.2% from 2025 to 2035, according to a new report by Orion Market Research. The global fiber optic connectivity market is developing steadily as organizations increasingly rely on advanced communication infrastructure to support expanding digital networks and data transmission requirements. Businesses, telecommunications operators, and service providers are handling growing volumes of data traffic generated by cloud platforms, enterprise applications, and connected digital services. Fiber optic connectivity solutions play a vital role in enabling stable, high-speed communication across modern network environments. These technologies are widely integrated within telecommunications networks, enterprise communication systems, and large-scale data center infrastructures to ensure reliable and efficient data transfer.

UK flexible electronics market was valued at $1,155.4 million in 2025 and is projected to reach $1,751.6 million by 2035, growing at a CAGR of 4.3% during the forecast period (2026-2035).  The rapid expansion of the UK’s digital health ecosystem is a primary demand driver for the flexible electronics market between 2024 and 2026. According to NHS England, remote monitoring, virtual wards, and digital-first healthcare delivery continue to scale nationwide as part of NHS transformation plans. The UK government’s 2024 Health and Social Care digitalization updates confirm continued investment in wearable diagnostics, remote patient monitoring, and connected medical technologies to reduce hospital admissions and improve chronic disease management. Flexible electronics are directly embedded in this transition, as wearable biosensors, skin patches, flexible ECG monitors, and smart bandages require bendable circuits, printed sensors, and lightweight conductive materials.

North American prostate cancer diagnostics and therapeutics market was valued at $8,678.3 million in 2025 and is projected to reach $21,066.4 million by 2035, growing at a CAGR of 9.3% during the forecast period (2026–2035). Canada represents a significant component of the North American prostate cancer diagnostics and therapeutics market, supported by a high disease burden and sustained clinical demand. In 2025, an estimated 30,400 men are expected to be diagnosed with prostate cancer, accounting for 23% of all new cancer cases among men in the country. Prostate cancer also remains the second leading cause of cancer-related death in Canadian men, with approximately 5,200 projected deaths, representing 11% of total male cancer mortality. 

North American flexible electronics market was valued at $6,288.0 million in 2025 and is projected to reach $10,808.1 million by 2035, growing at a CAGR of 5.6% during the forecast period (2026–2035). The continued expansion of OLED television sales in North America is a measurable demand-side driver for the regional flexible electronics market during 2024–2026. In Q1 2025, LG Electronics accounted for 51% of OLED TV unit sales across the US and Canada. Shipment data from Omdia (2013–2024) also indicates that the company has maintained the leading global share in OLED TV shipments for over a decade. OLED displays are based on organic emissive layers, thin-film transistor backplanes, and advanced substrate technologies that are closely aligned with flexible and printed electronics manufacturing processes.